New rapid test aims to get the right antibiotics to ICU patients faster

NCT ID NCT07403474

Not yet recruiting Disease control Sponsor: Centre Hospitalier Universitaire de Nīmes Source: ClinicalTrials.gov ↗

First seen Feb 13, 2026 · Last updated May 20, 2026 · Updated 13 times

Summary

This study tests whether a rapid molecular test combined with a treatment algorithm can help doctors choose the best antibiotics sooner for critically ill patients who develop pneumonia while on a ventilator. About 124 adults in two French hospitals will be randomly assigned to either the new test-based approach or standard care. The goal is to see if this strategy leads to more patients receiving effective, targeted antibiotics within 24 hours, reducing unnecessary broad-spectrum antibiotic use.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VENTILATOR ASSOCIATED PNEUMONIA (VAP) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

CHU Nîmes

Nîmes, 34070, France

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

VENTILATOR ASSOCIATED PNEUMONIA (VAP)